Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil

被引:24
|
作者
Achatz, Maria Isabel [1 ]
Caleffi, Maira [2 ,3 ]
Guindalini, Rodrigo [4 ,5 ]
Marques, Renato Moretti [6 ,7 ]
Nogueira-Rodrigues, Angelica [8 ,9 ,10 ]
Ashton-Prolla, Patricia [11 ,12 ]
机构
[1] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
[2] Nucleo Mama Porto Alegre, Porto Alegre, RS, Brazil
[3] Assoc Hosp Moinhos de Vento, Porto Alegre, RS, Brazil
[4] Rede DOr Sao Luiz, Oncol DOr, Rio De Janeiro, Brazil
[5] Univ Sao Paulo, Ctr Invest Translac Oncol, Inst Canc Estado Sao Paulo, Hosp Clin,Fac Med, Sao Paulo, Brazil
[6] Hosp Israelita Albert Einstein, Programa Saude Mulher, Sao Paulo, Brazil
[7] Hosp Israelita Albert Einstein, Ctr Oncol & Hematol, Sao Paulo, Brazil
[8] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[9] Grp Brasileiro Oncol Ginecol, Belo Horizonte, MG, Brazil
[10] DOM Oncol, Divinopolis, MG, Brazil
[11] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil
[12] Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil
关键词
BRCA MUTATION CARRIERS; NIPPLE-SPARING MASTECTOMY; COST-EFFECTIVENESS; HIGH-RISK; CONTRALATERAL MASTECTOMY; MAINTENANCE THERAPY; WOMEN; PANEL; TP53; SURVIVAL;
D O I
10.1200/JGO.19.00170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEThe objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC.METHODSA selected panel of Brazilian experts in fields related to HBOC was provided with a series of relevant questions to address before the multiday conference. During this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved.RESULTSThe authors propose specific and realistic recommendations for improving access to early diagnosis, risk management, and cancer care of HBOC specific to Brazil. Moreover, in creating these recommendations, the authors strived to address all the barriers and impediments mentioned in this article.CONCLUSIONThere is a great need to expand hereditary cancer testing and counseling in Brazil, and changing current policies is essential to accomplishing this goal. Increased knowledge and awareness, together with regulatory actions to increase access to this technology, have the potential to improve patient care and prevention and treatment efforts for patients with cancer across the country. (c) 2020 by American Society of Clinical Oncology
引用
收藏
页码:439 / 452
页数:14
相关论文
共 50 条
  • [41] Hereditary breast and ovarian cancers
    Gevensleben, H.
    Serce, N.
    Buettner, R.
    PATHOLOGE, 2010, 31 (06): : 438 - 444
  • [42] Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
    Moradian, Mike M.
    Babikyan, Davit T.
    Markarian, Sione
    Petrosyan, Jonny G.
    Avanesian, Nare
    Arutunyan, Tereza
    Sarkisian, Tamara F.
    HUMAN GENOME VARIATION, 2021, 8 (01)
  • [43] Genetic Counselling, Testing, and Management of Hereditary Breast and Ovarian Cancer Syndrome in India: Updated Expert Consensus Recommendations from Indian Society of Medical and Pediatric Oncology
    Malhotra, Hemant
    Pramanik, Raja
    Srinivas, Sujay
    Kotwal, Pradyna
    Mehra, Nikita
    Gupta, Sudeep
    Rajkumar, Thangarajan
    Sarin, Rajiv
    Kanakasetty, Govind Babu
    Bapna, Ajay
    Smruti, B. K.
    Sekhon, Rupinder
    Basade, Maheboob
    Gupta, Sabhayata
    Maheshwari, Amita
    Somashekhar, S. P.
    Kadayaprath, Geeta
    Krishnamurthy, Arvind
    Punia, Anushree
    Suryavanshi, Moushumi
    Gupta, Rekha
    Verma, Amit
    Kulkarni, Padmaj
    Parikh, Purvish
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2025,
  • [44] Is low-grade serous ovarian cancer part of the tumor spectrum of Hereditary Breast and Ovarian Cancer?
    Vineyard, Marisa A.
    Daniels, Molly S.
    Urbauer, Diana L.
    Deavers, Michael T.
    Sun, Charlotte C.
    Boerwinkle, Eric
    Bodurka, Diane C.
    Gershenson, David M.
    Crawford, Jessica
    Lu, Karen H.
    GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 229 - 232
  • [45] Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations
    McGuire, Kandace P.
    Arthur, Douglas W.
    Mamounas, Eleftherios P.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (11) : 6504 - 6507
  • [46] High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer
    Quinn, Gwendolyn P.
    Vadaparampil, Susan T.
    Miree, Cheryl A.
    Lee, Ji-Hyun
    Zhao, Xiuhua
    Friedman, Susan
    Yi, Susan
    Mayer, James
    HUMAN REPRODUCTION, 2010, 25 (10) : 2543 - 2550
  • [47] Prevalence and differentiation of hereditary breast and ovarian cancers in Japan
    Nakamura, Seigo
    Takahashi, Masato
    Tozaki, Mitsuhiro
    Nakayama, Takahiro
    Nomizu, Tadashi
    Miki, Yoshio
    Murakami, Yoshie
    Aoki, Daisuke
    Iwase, Takuji
    Nishimura, Seiichiro
    Yamauchi, Hideko
    Ohsumi, Shozo
    Baba, Shinichi
    Shimizu, Tadao
    BREAST CANCER, 2015, 22 (05) : 462 - 468
  • [48] Diagnosis of ovarian cancer
    Sundar, Sudha
    Neal, Richard D.
    Kehoe, Sean
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [49] Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
    Silva, Felipe C.
    Lisboa, Bianca C. G.
    Figueiredo, Marcia C. P.
    Torrezan, Giovana T.
    Santos, Erika M. M.
    Krepischi, Ana C.
    Rossi, Benedito M.
    Achatz, Maria I.
    Carraro, Dirce M.
    BMC MEDICAL GENETICS, 2014, 15
  • [50] Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort
    Bouras, Ahmed
    Guidara, Souhir
    Leone, Melanie
    Buisson, Adrien
    Martin-Denavit, Tanguy
    Dussart, Sophie
    Lasset, Christine
    Giraud, Sophie
    Bonnet-Dupeyron, Marie-Noelle
    Kherraf, Zine-Eddine
    Sanlaville, Damien
    Fert-Ferrer, Sandra
    Lebrun, Marine
    Bonadona, Valerie
    Calender, Alain
    Boutry-Kryza, Nadia
    CANCERS, 2023, 15 (13)